0.68p+0.00 (+0.00%)22 Nov 2024, 08:21
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Physiomics PLC Fundamentals

Company NamePhysiomics PLCLast Updated2024-11-22
IndustryBiotechnologySectorHealthcare
Shares in Issue203.209 mMarket Cap£1.37 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.4958Cash Equity Ratio0.6763
Quick Ratio2.4415Current Ratio2.87
Price To Book Value4.8544ROCE0

Physiomics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Physiomics PLC Company Financials

Assets2024202320222021
Tangible Assets£16,829.00£7,757.00£14,365.00£15,700.00
Intangible Assets£4,379.00£5,479.00£3,005.00£3,435.00
Investments0000
Total Fixed Assets£21,208.00£13,416.00£17,765.00£19,135.00
Stocks0000
Debtors£150,922.00£147,781.00£271,155.00£132,227.00
Cash & Equivalents£191,072.00£416,592.00£687,674.00£1.04 m
Other Assets0000
Total Assets£422,603.00£674,393.00£1.12 m£1.32 m
Liabilities2024202320222021
Creditors within 1 year£140,076.00£142,673.00£140,609.00£157,570.00
Creditors after 1 year0000
Other Liabilities0000
Total Liabilities£140,076.00£142,673.00£140,609.00£157,570.00
Net assets£282,527.00£531,720.00£974,807.00£1.17 m
Equity2024202320222021
Called up share capital£541,890.00£389,699.00£389,699.00£389,339.00
Share Premium£6.12 m£5.94 m£5.94 m£5.93 m
Profit / Loss-£668,754.00-£572,009.00-£358,972.00-£336,930.00
Other Equity£282,527.00£531,720.00£974,807.00£1.17 m
Preference & Minorities0000
Total Capital Employed£282,527.00£531,720.00£974,807.00£1.17 m
Ratios2024202320222021
Debt Ratio0000
Debt-to-Equity0000
Assets / Equity1.49581.49581.49581.4958
Cash / Equity0.67630.67630.67630.6763
EPS£-0.00£-0.00£-0.00£-0.00
Cash Flow2024202320222021
Cash from operating activities-£548,133.00-£266,587.00-£349,393.00-£32,607.00
Cashflow before financing-£210,305.00-£266,587.00-£346,548.00£11,633.00
Increase in Cash-£225,520.00-£271,082.00-£355,776.00-£4,410.00
Income2024202320222021
Turnover£543,250.00£597,354.00£830,266.00£702,314.00
Cost of sales0000
Gross Profit0000
Operating Profit-£670,816.00-£573,733.00-£359,114.00-£337,040.00
Pre-Tax profit-£668,754.00-£572,009.00-£358,972.00-£336,930.00

Physiomics PLC Company Background

SectorHealthcare
ActivitiesPhysiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA.
Latest Interim Date7 Mar 2024
Latest Fiscal Year End Date27 Sep 2024

Physiomics PLC Directors

AppointedNamePosition
2024-05-31Dr. Christophe D ChassagnoleExecutive Director,Chief Scientific Officer
2022-02-23Dr. Paul Bernard HarperNon-Executive Director,Chairman
2007-06-30Mr. John Kingston PoolNon-Executive Director,Chairman
2006-08-29Mr. Duncan John LipscombeNon-Executive Director
2017-11-09Mr. Mark Philip ChadwickNon-Executive Director
2024-10-17Dr. James Simon MillenNon-Executive Director,Chairman
2024-11-08Dr. Peter Joseph SargentExecutive Director,Chief Executive Officer

Physiomics PLC Contact Details

Company NamePhysiomics PLC
AddressThe Magdalen Centre, Robert Robinson Avenue, Oxford, OX4 4GA
Telephone+44 1865784980
Websitehttps://www.physiomics.co.uk

Physiomics PLC Advisors

StockbrokerHybridan LLP
Phone+44 203764 2341
Fax+44 2076001586
Financial AdviserWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897
AuditorShipleys LLP
Phone+44 2073120000
Fax+44 2073120022
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserCommunications Portfolio (The)
Phone020 7536 2028
StockbrokerWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897
SolicitorTaylor Vinters
Phone+44 1223423444
Fax+44 1223423486
Nominated AdviserWH Ireland Ltd
Phone0161 832 2174
Fax0161 819 8897